Emily H Cheng Selected Research

Emily H Cheng Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 05/2013
13	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2013
8	Kidney Neoplasms (Kidney Cancer) 01/2022 - 04/2014
5	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2014
4	Leukemia 10/2015 - 04/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2018 - 04/2003
2	Carcinogenesis 01/2017 - 11/2014
1	Hypersensitivity (Allergy) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Bites and Stings (Sting) 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017
1	Oncogene Addiction 10/2015
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2014
1	Genetic Translocation (Chromosomal Translocation) 04/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2003
5	Biomarkers (Surrogate Marker)IBA 10/2018 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 04/2014
3	Sunitinib (Sutent)FDA Link 10/2018 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	ChromatinIBA 01/2022 - 05/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2017
2	Everolimus FDA Link 01/2019 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2018 - 01/2016
2	Glutathione (Reduced Glutathione)IBA 12/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 11/2016
2	MTOR InhibitorsIBA 01/2016 - 04/2014
2	Peptide Hydrolases (Proteases)FDA Link 10/2015 - 11/2014
1	Histone ChaperonesIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2022
1	TransposasesIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	osimertinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Aurora Kinase BIBA 01/2021
1	InterferonsIBA 11/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2020
1	Sugar AlcoholsIBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	LipidsIBA 01/2019
1	GlycogenIBA 01/2019
1	temsirolimus FDA Link 01/2019
1	Sorbitol (Yal)FDA Link 01/2019
1	Axitinib (AG 013736)IBA 10/2018
1	lenvatinibIBA 10/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2018
1	cabozantinibIBA 10/2018
1	CytokinesIBA 10/2018
1	Sorafenib (BAY 43-9006)FDA Link 10/2018
1	Bevacizumab (Avastin)FDA Link 10/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2018
1	B7-H1 AntigenIBA 10/2018
1	pazopanib FDA Link 10/2018
1	CaspasesIBA 06/2018
1	Phenobarbital (Luminal)FDA Link 12/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Oxygen (Dioxygen)IBA 11/2017
1	Biological ProductsIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	Histocompatibility Antigens Class IIBA 11/2016
1	AntigensIBA 11/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	CarbonIBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	AntioxidantsIBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2015
1	Transcription Factor TFIIA (TFIIA)IBA 11/2014
1	Threonine (L-Threonine)FDA Link 11/2014
1	CyclinsIBA 11/2014
1	Cyclin EIBA 11/2014
1	E2F Transcription FactorsIBA 11/2014
1	AsparagineIBA 10/2014
1	Asparaginase (Elspar)FDA Link 10/2014
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 10/2014
1	Glutamine (L-Glutamine)FDA Link 10/2014
1	Bortezomib (Velcade)FDA Link 04/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2014
1	Proteasome InhibitorsIBA 04/2014
1	Caspase 8 (Caspase-8)IBA 04/2014
1	carfilzomibIBA 04/2014

Therapy/Procedure

14	Therapeutics 01/2021 - 05/2013
3	Precision Medicine 12/2018 - 12/2016
1	Nephrectomy 01/2017
1	Immunotherapy 11/2016